losartan and carvedilol

losartan has been researched along with carvedilol in 37 studies

Research

Studies (37)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (5.41)	18.2507
2000's	23 (62.16)	29.6817
2010's	12 (32.43)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Funakoshi, J; Kakumoto, M; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Böhm, M; Buikema, H; Flesch, M; Paul, M; Pinto, YM; Teisman, AC; van Gilst, WH	1
Anguita Sánchez, M	1
Armstrong, PW; Borer, J; Fleming, T; Pfeffer, M	1
Chen, JL; Chen, ZJ; Gao, RL; Ruan, YM; Tang, YD; Wang, PH; Yang, YJ; Zhang, P; Zhou, YW	1
Chi, JL; Li, J; Li, SA; Sui, XT	1
Barouhiel, E; Cabassi, A; Cantoni, AM; Cavazzini, S; Coghi, P; Fiaccadori, E; Govoni, P; Scandroglio, R; Speroni, E	1
Baruch, L; Kunamneni, P	1
Chen, Z; Gao, R; Li, Y; Ruan, Y; Tang, Y; Yang, Y	1
Biedunkiewicz, B; Chamienia, A; Rutkowski, B; Tylicki, L; Wojnarowski, K; Zdrojewski, Z	1
Devereux, RB; Krauser, DG	1
Calabrò, R; Natale, F; Tedesco, MA	1
Aleksandrowicz, E; Biedunkiewicz, B; Chamienia, A; Lysiak-Szydlowska, W; Rutkowski, B; Tylicki, L; Wojnarowski, K; Zdrojewski, Z	1
Akdag, I; Arabul, M; Dilek, K; Ersoy, A; Gullulu, M; Kahvecioglu, S; Yavuz, M; Yurtkuran, M	1
Bacal, F; Bocchi, EA; Chizzola, PR; Guimarães, GV; Issa, VS; Mangini, S; Moreira, SF; Pires, PV; Silva, CP; Souza, GE	1
Altieri, PI; Crespo, MJ; Cruz, N; Escobales, N	1
Chang, LT; Chua, S; Lee, FY; Sheu, JJ; Sun, CK; Wu, CJ; Yip, HK	1
Bocchi, EA; Carvalho, VO; Guimarães, GV	1
Abdulla, MH; Abdullah, NA; Johns, EJ; Khan, MA; Sattar, MA	1
Antelava, N; Bejitashvili, N; Gabunia, L; Gambashidze, K; Petriashvili, Sh	1
Abdallah, HH; Abdulla, MH; Abdullah, NA; Johns, EJ; Khan, MA; Sattar, MA	1
Ahmed, D; Clark, AL; Cleland, JG; Coletta, AP; Freemantle, N; Rubis, P	1
Dvorák, J; Kupec, J; Málek, F; Neuzil, P; Petrů, J; Sedivá, L; Táborský, M; Vondráková, D	1
Abdulla, MH; Abdullah, NA; Johns, EJ; Sattar, MA	1
Jouyban, A; Ramezani, AM; Soltani, N; Soltani, S	1
Han, SW; Hong, KS; Kim, BO; Kim, EJ; Lee, JU; Lee, S; Park, CG; Seo, HS; Shin, MS; Song, WH	1
Salvi, P	1
Battista, F; Pucci, G; Schillaci, G	1
Horvath, KM; Riezebos, R; Smits, P; Thiesbrummel, H; van Bolhuis, H; van der Hulst, V; van Zijll Langhout, M; Wolters, M	1

Reviews

3 review(s) available for losartan and carvedilol

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Beta-blockers in heart failure: is more better? Current heart failure reports, 2004, Volume: 1, Issue:2 Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Heart Failure; Humans; Losartan; Metoprolol; Propanolamines; Prospective Studies; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Sympathetic Nervous System	2004
Ventricular hypertrophy and hypertension: prognostic elements and implications for management. Herz, 2006, Volume: 31, Issue:4 Topics: Adrenergic Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Carbazoles; Carvedilol; Chi-Square Distribution; Cohort Studies; Coronary Disease; Death, Sudden, Cardiac; Diuretics; Drug Therapy, Combination; Echocardiography; Electroencephalography; Enalapril; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Logistic Models; Losartan; Male; Multivariate Analysis; Prognosis; Propanolamines; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Sex Factors; Stroke; Survival Analysis; Telmisartan	2006

Trials

6 trial(s) available for losartan and carvedilol

Article	Year
[Clinical observation of 41 cases of senile ischemic heart disease treated by losarton, carvadilol and Shenmai Injection]. Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine, 2003, Volume: 1, Issue:4 Topics: Aged; Carbazoles; Carvedilol; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Losartan; Male; Middle Aged; Myocardial Ischemia; Propanolamines	2003
Randomized placebo-controlled study on the effects of losartan and carvedilol on albuminuria in renal transplant recipients. Transplantation, 2006, Jan-15, Volume: 81, Issue:1 Topics: Albuminuria; Blood Pressure; Carbazoles; Carvedilol; Cyclosporine; Female; Humans; Kidney Function Tests; Kidney Transplantation; Losartan; Male; Middle Aged; Placebos; Propanolamines	2006
Effects of monotherapy and combination therapy on blood pressure control and target organ damage: a randomized prospective intervention study in a large population of hypertensive patients. Journal of clinical hypertension (Greenwich, Conn.), 2006, Volume: 8, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Carbazoles; Cardiovascular Diseases; Carvedilol; Drug Therapy, Combination; Enalapril; Humans; Hypertension; Losartan; Male; Middle Aged; Propanolamines; Ultrasonography	2006
Renal allograft protection with angiotensin II type 1 receptor antagonists. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2007, Volume: 7, Issue:1 Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Carbazoles; Carvedilol; Cross-Over Studies; Double-Blind Method; Female; Fibrosis; Humans; Kidney; Kidney Transplantation; Kidney Tubules; Losartan; Male; Middle Aged; Propanolamines; Protective Agents; Proteinuria	2007
Comparison of higher dose of losartan treatment with losartan plus carvedilol and losartan plus ramipril in patients with glomerulonephritis and proteinuria. Renal failure, 2007, Volume: 29, Issue:2 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Carbazoles; Carvedilol; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Glomerulonephritis; Humans; Losartan; Propanolamines; Proteinuria; Ramipril; Treatment Outcome; Vasodilator Agents	2007
Efficacy of losartan and carvedilol on central hemodynamics in hypertensives: a prospective, randomized, open, blinded end point, multicenter study. Hypertension research : official journal of the Japanese Society of Hypertension, 2014, Volume: 37, Issue:1 Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Carbazoles; Carvedilol; Drug Therapy, Combination; Endpoint Determination; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Inflammation; Losartan; Male; Middle Aged; Propanolamines; Prospective Studies; Pulse Wave Analysis	2014

Other Studies

28 other study(ies) available for losartan and carvedilol

Article	Year
Interaction of digoxin with antihypertensive drugs via MDR1. Life sciences, 2002, Feb-15, Volume: 70, Issue:13 Topics: Animals; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Digoxin; Drug Interactions; Humans; Time Factors	2002
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling. Journal of medicinal chemistry, 2013, Feb-14, Volume: 56, Issue:3 Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs	2013
Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats. Journal of hypertension, 1998, Volume: 16, Issue:12 Pt 1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Carbazoles; Carvedilol; Heart Function Tests; Hydralazine; Hypertension; Isoquinolines; Losartan; Norepinephrine; Propanolamines; Quinapril; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Tetrahydroisoquinolines	1998
[Arterial hypertension and systolic left ventricular dysfunction: therapeutic approach]. Revista espanola de cardiologia, 1999, Volume: 52 Suppl 3 Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Carbazoles; Carvedilol; Clinical Trials as Topic; Databases, Bibliographic; Felodipine; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Meta-Analysis as Topic; Propanolamines; Randomized Controlled Trials as Topic; Risk Factors; Systole; Vasodilator Agents; Ventricular Dysfunction, Left	1999
Food and Drug Administration: Cardiovascular and Renal Drugs Advisory Committee, 98th meeting, January 6th-7th, 2003. Circulation, 2003, Jan-21, Volume: 107, Issue:2 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Atenolol; Carbazoles; Carvedilol; Drug Approval; Humans; Hypertension; Losartan; Middle Aged; Myocardial Infarction; Propanolamines; Racial Groups; Randomized Controlled Trials as Topic; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Risk; Stroke; Treatment Outcome; United States; United States Food and Drug Administration	2003
Comparative effects of carvedilol and losartan alone and in combination for preventing left ventricular remodeling after acute myocardial infarction in rats. Circulation journal : official journal of the Japanese Circulation Society, 2003, Volume: 67, Issue:2 Topics: Animals; Carbazoles; Carvedilol; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Heart Ventricles; Hemodynamics; Losartan; Myocardial Infarction; Propanolamines; Rats; Rats, Sprague-Dawley; Ventricular Remodeling	2003
Sympathetic modulation by carvedilol and losartan reduces angiotensin II-mediated lipolysis in subcutaneous and visceral fat. The Journal of clinical endocrinology and metabolism, 2005, Volume: 90, Issue:5 Topics: Adipocytes; Adipose Tissue; Angiotensin II; Animals; Blood Pressure; Body Weight; Carbazoles; Carvedilol; Glycerol; Heart Rate; Lipolysis; Losartan; Male; Norepinephrine; Propanolamines; Rats; Rats, Sprague-Dawley; Sterol Esterase; Sympathetic Nervous System; Triglycerides; Tyrosine 3-Monooxygenase	2005
Researched Medicines Industry (RMI) Code of Practice complaints 2004. The New Zealand medical journal, 2005, Jul-29, Volume: 118, Issue:1219 Topics: Advertising; Benzimidazoles; Biphenyl Compounds; Carbazoles; Carvedilol; Codes of Ethics; Dissent and Disputes; Drug Industry; Humans; Losartan; New Zealand; Propanolamines; Tetrazoles	2005
[Comparative effects of carvedilol, losartan and their combination in preventing left ventricular remodeling after acute myocardial infarction in rats]. Zhonghua nei ke za zhi, 2001, Volume: 40, Issue:12 Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Carbazoles; Carvedilol; Drug Therapy, Combination; Female; Hemodynamics; Losartan; Myocardial Infarction; Propanolamines; Rats; Rats, Sprague-Dawley; Ventricular Function, Left; Ventricular Remodeling	2001
Heart failure treatment profile at the beta blockers era. Arquivos brasileiros de cardiologia, 2007, Volume: 88, Issue:4 Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Losartan; Male; Middle Aged; Propanolamines; Severity of Illness Index	2007
Enalapril and losartan are more effective than carvedilol in preventing dilated cardiomyopathy in the Syrian cardiomyopathic hamster. Journal of cardiovascular pharmacology and therapeutics, 2008, Volume: 13, Issue:3 Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Carbazoles; Cardiac Output; Cardiomyopathy, Dilated; Carvedilol; Cricetinae; Disease Models, Animal; Disease Progression; Enalapril; Losartan; Male; Mesocricetus; Propanolamines; Renin-Angiotensin System; Stroke Volume; Time Factors; Ultrasonography; Ventricular Function, Left	2008
Comparison of losartan and carvedilol on attenuating inflammatory and oxidative response and preserving energy transcription factors and left ventricular function in dilated cardiomyopathy rats. International heart journal, 2008, Volume: 49, Issue:5 Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Connexin 43; Losartan; Male; Oxidative Stress; Propanolamines; Rats; Rats, Sprague-Dawley; Transcription Factors; Ventricular Function, Left	2008
The relationship between heart rate reserve and oxygen uptake reserve in heart failure patients on optimized and non-optimized beta-blocker therapy. Clinics (Sao Paulo, Brazil), 2008, Volume: 63, Issue:6 Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Losartan; Male; Middle Aged; Oxygen Consumption; Propanolamines	2008
Influence of sympathetic and AT-receptor blockade on angiotensin II and adrenergic agonist-induced renal vasoconstrictions in spontaneously hypertensive rats. Acta physiologica (Oxford, England), 2009, Volume: 195, Issue:3 Topics: Adrenergic Agonists; Adrenergic alpha-Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Carbazoles; Carvedilol; Drug Interactions; Hypertension; Kidney; Losartan; Male; Propanolamines; Rats; Rats, Inbred SHR; Renal Circulation; Sympathetic Nervous System; Vasoconstriction; Vasoconstrictor Agents	2009
Effects of carvedilol, losartan and trimetazidin on functional parameters of isolated heart of rats at oxidative stress. Georgian medical news, 2009, Issue:167 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Carbazoles; Carvedilol; Heart Rate; Losartan; Oxidative Stress; Propanolamines; Rats; Trimetazidine; Vasodilator Agents	2009
Chronic treatment with losartan and carvedilol differentially modulates renal vascular responses to sympathomimetics compared to treatment with individual agents in normal Wistar Kyoto and spontaneously hypertensive rats. European journal of pharmacology, 2009, Jun-10, Volume: 612, Issue:1-3 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Drug Combinations; Heart Rate; Kidney; Losartan; Male; Propanolamines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Regional Blood Flow; Sympathomimetics; Time Factors	2009
Clinical trials update from the American Heart Association meeting 2009: HEAAL, FAIR-HF, J-CHF, HeartMate II, PACE and a meta-analysis of dose-ranging studies of beta-blockers in heart failure. European journal of heart failure, 2010, Volume: 12, Issue:2 Topics: Adrenergic beta-Antagonists; Aged; American Heart Association; Antihypertensive Agents; Carbazoles; Carvedilol; Clinical Trials as Topic; Female; Heart Failure; Heart-Assist Devices; Humans; Iron Compounds; Losartan; Male; Meta-Analysis as Topic; Middle Aged; Propanolamines; United States	2010
Critical evaluation of the optimal medical therapy in the cardiac resynchronization therapy candidates--single centre experience. Vnitrni lekarstvi, 2011, Volume: 57, Issue:10 Topics: Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Carbazoles; Cardiac Resynchronization Therapy; Carvedilol; Defibrillators, Implantable; Enalapril; Female; Heart Failure; Humans; Losartan; Male; Propanolamines	2011
The effect of losartan and carvedilol on renal haemodynamics and altered metabolism in fructose-fed Sprague-Dawley rats. Journal of physiology and biochemistry, 2012, Volume: 68, Issue:3 Topics: Angiotensin II; Animals; Body Weight; Carbazoles; Carvedilol; Fructose; Glucose Tolerance Test; Hemodynamics; Insulin Resistance; Kidney; Losartan; Male; Norepinephrine; Phenylephrine; Propanolamines; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents	2012
Analysis of losartan and carvedilol in urine and plasma samples using a dispersive liquid-liquid microextraction isocratic HPLC-UV method. Bioanalysis, 2012, Volume: 4, Issue:23 Topics: Antihypertensive Agents; Carbazoles; Carvedilol; Chromatography, High Pressure Liquid; Half-Life; Humans; Hydrogen-Ion Concentration; Liquid Phase Microextraction; Losartan; Propanolamines; Salts; Solvents; Spectrophotometry, Ultraviolet; Urinalysis	2012
Is validation of non-invasive hemodynamic measurement devices actually required? Hypertension research : official journal of the Japanese Society of Hypertension, 2014, Volume: 37, Issue:1 Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Carbazoles; Carvedilol; Female; Hemodynamics; Humans; Hypertension; Losartan; Male; Propanolamines	2014
Effects of antihypertensive drugs on central blood pressure: new evidence, more challenges. Hypertension research : official journal of the Japanese Society of Hypertension, 2014, Volume: 37, Issue:1 Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Carbazoles; Carvedilol; Female; Hemodynamics; Humans; Hypertension; Losartan; Male; Propanolamines	2014
Clinical signs, diagnostics and successful treatment of a myocarditis in an adult chimpanzee (Pan troglodytes). Journal of medical primatology, 2017, Volume: 46, Issue:5 Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Ape Diseases; Carbazoles; Carvedilol; Female; Losartan; Myocarditis; Pan troglodytes; Propanolamines; Treatment Outcome	2017